Managing HIV/AIDS Therapy in Treatment-Experienced Patients Program Menu As the second program in a three-part series on optimizing HIV/AIDS therapy, "Managing HIV/AIDS Therapy in Treatment-Experienced Patients" is a continuing medical education (CME) program offering up-to-date information and clinical insights on selection of antiretroviral therapy for treatment of HIV and AIDS (autoimmune deficiency syndrome) in patients who have been previously treated for HIV or AIDS - patients ranging from those requiring an initial change in regimen to those requiring salvage therapy. The program content consists of videotaped interviews with three leading clinicians with vast experience in treatment of all types of HIV-positive patients and patients with AIDS. The program also includes an interactive patient case. The key learning segments of the program requires Microsoft Media Player software [Download] and consists of streaming video segments of the faculty interviews, together with text of the physician's responses. Click on the links below for the segment you want to view. Accreditation Statement Statement of Need/Program Overview Faculty Information Faculty Disclosures Learning Objectives Method of Participation Interview Topics What are the treatment goals for treatment-experienced patients? What are the reasons behind treatment failure? How do you assess a patient failing treatment? What are the key factors in making the decision to change therapy? When do you use a non-nucleoside regimen? When do you switch out a PI-based regimen? How do you handle a patient with limited prior treatment and low viral load? What can be done for a patient with limited prior treatment and single drug resistance? What about a patient with limited prior experience and multiple drug resistance? What if there is failure with no resistance identified? Can physicians predict non-adherence in their patients? Why do patients miss their doses? Are dietary restrictions more important to patient than increased dosing intervals? Are dietary restrictions more important to patients than pill burden? How do you handle the patient who demands a specific drug or regimen? Are once-daily regimens just as potent as twice daily regimens? What are some switching strategies for lipodystrophy? What switches should be made for dyslipidemia? What key lessons have been learned about salvage regimens? Are double-boosted PI regimens valid options for salvage? What is your final advice on treatment failure and switching? Interactive Case Study: Treatment Experienced Patient Demands Change of Therapy Post Test, Evaluation and Request for Credit (PDF format) Suggested Reading List   Series Menu